Eligibility, uptake and response to germline genetic testing in women with DCIS

Eligibility, uptake and response to germline genetic testing in women with DCIS

BackgroundDuctal carcinoma in situ (DCIS) is a malignant, yet pre-invasive disease of the breast. While the majority of DCIS have low risk of recurrence, a subset of women with germline pathogenic variants (PV) in cancer predisposition genes are at increased risk for recurrence. Uptake of genetic te...

Descripció completa

Dades bibliogràfiques
Autors principals: Lauren Turza, Leann A. Lovejoy, Clesson E. Turner, Craig D. Shriver, Rachel E. Ellsworth
Format: Article
Idioma:English
Publicat: Frontiers Media S.A. 2022-08-01
Col·lecció:Frontiers in Oncology
Matèries:
ductal carcinoma in situ
genetic testing
germline mutation
risk-reducing surgery
recurrence
Accés en línia:https://www.frontiersin.org/articles/10.3389/fonc.2022.918757/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.918757/full

Ítems similars